Forum Discussions

Forum Discussions

These novel Fora, in WEF-style format, will bring together corporate participants, neuroscientists and clinicians with outstanding experience in “hottest” research topics in the field of neurodegeneration to discuss the impact of newest preclinical results and cutting edge clinical findings on understanding and treatment development of neurodegenerative disorders. The objective is to exchange novel insights, challenges and solutions on the joint path forward to defining the future of Alzheimer’s and Parkinson’s therapeutics.

Each forum will be a moderated discussion with maximum 3 minutes introduction statement from each participant followed by questions from the audience submitted via Ask the Speaker function in the mobile APP and introduced to the discussion by the moderator. The forum is also open for journalists from different media, including lay press in and may report on progress made by the leaders in this field.

FORUM TITLE

Co-Moderators

Dates

FORUM ON IMPACT OF COVID-19 ON NEURODEGENERATIVE DISEASES

Roger Nitsch (Switzerland)
Ronald Petersen (USA)

March 10, 2021

FORUM ON APPLICATIONS OF NEUROPSYCHOLOGY, PET, MRI, EEG, AND CSF FOR DIAGNOSIS AND ASSESSMENT OF TREATMENT EFFECTS

Henrik Zetterberg (Sweden)
Melissa Murray (USA)

March 10, 2021

FORUM ON TRANSLATIONAL DRUG DISCOVERY IN PD/ LBD PHASE I-III –  RECENT UPDATES

Jamie Eberling (USA)
Walter Koroshetz (USA)

March 11, 2021

FORUM ON PHASE I-II CLINICAL TRIALS IN ALZHEIMER’S DISEASE

Jeffrey Cummings (USA)
Manfred Windisch (Austria)

March 12, 2021

FORUM ON PHASE III CLINICAL TRIALS IN ALZHEIMER’S DISEASE

Selina Koch (USA)
John Morris (USA)

March 13, 2021